comparemela.com

Clear Harbor Asset Management LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 21.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,693 shares of the financial services provider’s stock after selling 996 […]

Related Keywords

,Exchange Commission ,Column Capital Advisors ,Path Wealth Partners ,Nasdaq ,Nasdaq Biotechnology Index Fund ,Hb Wealth Management ,Clear Harbor Asset Management ,Householder Group Estate Retirement Specialist ,Shares Biotechnology ,Free Report ,Harbor Asset Management ,Wealth Management ,Group Estate ,Retirement Specialist ,Capital Advisors ,Premier Path Wealth Partners ,Shares Nasdaq Biotechnology ,Shares Nasdaq Biotechnology Index Fund ,Industry Classification Benchmark ,Visit Holdingschannel ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.